183 related articles for article (PubMed ID: 17925731)
1. [Gastrointestinal carcinoid tumors: a multi-technique diagnostic approach].
Mathonnet M
J Chir (Paris); 2007; 144(4):287-92. PubMed ID: 17925731
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal carcinoids: the evolution of diagnostic strategies.
Modlin IM; Latich I; Zikusoka M; Kidd M; Eick G; Chan AK
J Clin Gastroenterol; 2006 Aug; 40(7):572-82. PubMed ID: 16917396
[TBL] [Abstract][Full Text] [Related]
3. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
Eriksson B; Bergström M; Lilja A; Ahlström H; Långström B; Oberg K
Acta Oncol; 1993; 32(2):189-96. PubMed ID: 7686763
[TBL] [Abstract][Full Text] [Related]
5. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors.
Welin S; Stridsberg M; Cunningham J; Granberg D; Skogseid B; Oberg K; Eriksson B; Janson ET
Neuroendocrinology; 2009; 89(3):302-7. PubMed ID: 19176944
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
8. Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors.
Khan MU; Morse M; Coleman RE
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):441-54. PubMed ID: 19088697
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
[TBL] [Abstract][Full Text] [Related]
10. Standard imaging techniques for neuroendocrine tumors.
Bushnell DL; Baum RP
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):153-62, ix. PubMed ID: 21349416
[TBL] [Abstract][Full Text] [Related]
11. Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies.
Eriksson B; Bergström M; Orlefors H; Sundin A; Oberg K; Långström B
Q J Nucl Med; 2000 Mar; 44(1):68-76. PubMed ID: 10932603
[TBL] [Abstract][Full Text] [Related]
12. The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center.
Nikolaou A; Thomas D; Kampanellou C; Alexandraki K; Andersson LG; Sundin A; Kaltsas G
J Endocrinol Invest; 2010 Dec; 33(11):794-9. PubMed ID: 20332708
[TBL] [Abstract][Full Text] [Related]
13. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
[TBL] [Abstract][Full Text] [Related]
14. Carcinoid tumors of the gastrointestinal tract.
Ghevariya V; Malieckal A; Ghevariya N; Mazumder M; Anand S
South Med J; 2009 Oct; 102(10):1032-40. PubMed ID: 19738517
[TBL] [Abstract][Full Text] [Related]
15. Carcinoid tumours.
Tiensuu Janson EM; Oberg KE
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):589-601. PubMed ID: 9113314
[TBL] [Abstract][Full Text] [Related]
16. Carcinoid syndrome: diagnosis and medical management.
van der Lely AJ; de Herder WW
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):850-60. PubMed ID: 16444370
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid tumors: imaging procedures and interventional radiology.
Wallace S; Ajani JA; Charnsangavej C; DuBrow R; Yang DJ; Chuang VP; Carrasco CH; Dodd GD
World J Surg; 1996 Feb; 20(2):147-56. PubMed ID: 8661810
[TBL] [Abstract][Full Text] [Related]
18. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
[TBL] [Abstract][Full Text] [Related]
19. Catecholamine-secreting metastatic carcinoid as differential diagnosis in pheochromocytoma: clinical, laboratory, and imaging clues in the search for the lurking neuroendocrine tumor (NET).
Whitman HH; Fishman EK; Oberg K; Wildman JM; Long AL
Ann N Y Acad Sci; 2006 Aug; 1073():59-78. PubMed ID: 17102073
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
